Cambridge Investment Research Advisors’s Goldman Sachs ActiveBeta Emerging Markets Equity ETF GEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$552K Sell
12,774
-339
-3% -$15.2K ﹤0.01% 2697
2025
Q4
$546K Sell
13,113
-50
-0.4% -$2.08K ﹤0.01% 2637
2025
Q3
$536K Buy
13,163
+3,449
+36% +$133K ﹤0.01% 2610
2025
Q2
$361K Sell
9,714
-203
-2% -$6.97K ﹤0.01% 2825
2025
Q1
$329K Sell
9,917
-1,373
-12% -$45.2K ﹤0.01% 2780
2024
Q4
$360K Sell
11,290
-1,445
-11% -$49K ﹤0.01% 2689
2024
Q3
$447K Sell
12,735
-129,986
-91% -$4.29M ﹤0.01% 2496
2024
Q2
$4.66M Sell
142,721
-5,558
-4% -$178K 0.02% 796
2024
Q1
$4.65M Sell
148,279
-18,626
-11% -$567K 0.02% 788
2023
Q4
$5.12M Buy
166,905
+2,440
+1% +$71.2K 0.02% 690
2023
Q3
$4.71M Sell
164,465
-426
-0.3% -$12.7K 0.02% 681
2023
Q2
$4.93M Sell
164,891
-4,212
-2% -$126K 0.02% 665
2023
Q1
$5.03M Buy
169,103
+18,251
+12% +$545K 0.02% 620
2022
Q4
$4.27M Sell
150,852
-14,155
-9% -$388K 0.02% 673
2022
Q3
$4.26M Sell
165,007
-6,611
-4% -$191K 0.02% 640
2022
Q2
$5.11M Buy
171,618
+14,400
+9% +$455K 0.03% 581
2022
Q1
$5.33M Sell
157,218
-7,100
-4% -$253K 0.02% 609
2021
Q4
$6.08M Buy
164,318
+3,884
+2% +$144K 0.03% 570
2021
Q3
$5.95M Buy
160,434
+6,991
+5% +$272K 0.03% 537
2021
Q2
$6.26M Buy
153,443
+14,401
+10% +$582K 0.03% 521
2021
Q1
$5.49M Buy
139,042
+21,001
+18% +$842K 0.03% 528
2020
Q4
$4.51M Buy
118,041
+9,381
+9% +$332K 0.03% 565
2020
Q3
$3.56M Buy
108,660
+7,710
+8% +$254K 0.02% 569
2020
Q2
$3.06M Buy
100,950
+8,793
+10% +$252K 0.02% 608
2020
Q1
$2.41M Buy
92,157
+73,291
+388% +$2.31M 0.02% 596
2019
Q4
$648K Buy
18,866
+7,261
+63% +$238K 0.01% 1415
2019
Q3
$364K Buy
+11,605
New +$370K ﹤0.01% 1705
2018
Q1
Sell
-29,007
Closed -$1.04M 2184
2017
Q4
$1.04M Buy
+29,007
New +$1.01M 0.01% 889

Other funds holding GEM

Cambridge Investment Research Advisors's GEM Position: Q1 2026 in Review

Cambridge Investment Research Advisors reduced its Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) stake by 2.6% in Q1 2026, selling an estimated $15.2K and leaving 12,774 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #2697.

Cambridge Investment Research Advisors first reported a position in GEM in Q4 2017 and has held it in 28 quarters since. The position peaked at $6.26M in Q2 2021. 181 funds tracked by Wall St. Rank hold GEM as of Q1 2026.

  • Cambridge Investment Research Advisors held 12,774 shares of Goldman Sachs ActiveBeta Emerging Markets Equity ETF worth $552K as of Q1 2026.
  • Cambridge Investment Research Advisors sold 339 Goldman Sachs ActiveBeta Emerging Markets Equity ETF shares in Q1 2026, an estimated $15.2K.
  • Goldman Sachs ActiveBeta Emerging Markets Equity ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #2697 holding.
  • Cambridge Investment Research Advisors first reported a position in Goldman Sachs ActiveBeta Emerging Markets Equity ETF in Q4 2017 and has held it in 28 quarters since.
  • Cambridge Investment Research Advisors's Goldman Sachs ActiveBeta Emerging Markets Equity ETF position peaked at $6.26M in Q2 2021.
  • 181 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta Emerging Markets Equity ETF as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.